Global Biosimilar Drug Market Insights, Forecast to 2025
SKU ID :QYR-13729938 | Published Date: 05-Mar-2019 | No. of pages: 116Description
TOC
Table of Contents
1 Study Coverage
1.1 Biosimilar Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biosimilar Drug Market Size Growth Rate by Product
1.4.2 Injection
1.4.3 Tablets
1.4.4 Other Types
1.5 Market by End User
1.5.1 Global Biosimilar Drug Market Size Growth Rate by End User
1.5.2 Ankylosing Spondylitis
1.5.3 Tumor
1.5.4 Rheumatoid Arthrtis
1.5.5 Cardiovascular
1.5.6 Other Application
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size
2.1.1 Global Biosimilar Drug Revenue 2014-2025
2.1.2 Global Biosimilar Drug Sales 2014-2025
2.2 Biosimilar Drug Growth Rate by Regions
2.2.1 Global Biosimilar Drug Sales by Regions
2.2.2 Global Biosimilar Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biosimilar Drug Sales by Manufacturers
3.1.1 Biosimilar Drug Sales by Manufacturers
3.1.2 Biosimilar Drug Sales Market Share by Manufacturers
3.1.3 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar Drug Revenue by Manufacturers
3.2.1 Biosimilar Drug Revenue by Manufacturers (2014-2019)
3.2.2 Biosimilar Drug Revenue Share by Manufacturers (2014-2019)
3.3 Biosimilar Drug Price by Manufacturers
3.4 Biosimilar Drug Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Drug Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biosimilar Drug Sales by Product
4.2 Global Biosimilar Drug Revenue by Product
4.3 Biosimilar Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biosimilar Drug Breakdown Data by End User
6 North America
6.1 North America Biosimilar Drug by Countries
6.1.1 North America Biosimilar Drug Sales by Countries
6.1.2 North America Biosimilar Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biosimilar Drug by Product
6.3 North America Biosimilar Drug by End User
7 Europe
7.1 Europe Biosimilar Drug by Countries
7.1.1 Europe Biosimilar Drug Sales by Countries
7.1.2 Europe Biosimilar Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilar Drug by Product
7.3 Europe Biosimilar Drug by End User
8 Asia Pacific
8.1 Asia Pacific Biosimilar Drug by Countries
8.1.1 Asia Pacific Biosimilar Drug Sales by Countries
8.1.2 Asia Pacific Biosimilar Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biosimilar Drug by Product
8.3 Asia Pacific Biosimilar Drug by End User
9 Central & South America
9.1 Central & South America Biosimilar Drug by Countries
9.1.1 Central & South America Biosimilar Drug Sales by Countries
9.1.2 Central & South America Biosimilar Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biosimilar Drug by Product
9.3 Central & South America Biosimilar Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar Drug by Countries
10.1.1 Middle East and Africa Biosimilar Drug Sales by Countries
10.1.2 Middle East and Africa Biosimilar Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biosimilar Drug by Product
10.3 Middle East and Africa Biosimilar Drug by End User
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Biosimilar Drug Products Offered
11.1.5 Amgen Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eli Lilly Biosimilar Drug Products Offered
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Biosimilar Drug Products Offered
11.3.5 Novartis Recent Development
11.4 CP Guojian Pharma
11.4.1 CP Guojian Pharma Company Details
11.4.2 Company Business Overview
11.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 CP Guojian Pharma Biosimilar Drug Products Offered
11.4.5 CP Guojian Pharma Recent Development
11.5 Biotech Pharma
11.5.1 Biotech Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Biotech Pharma Biosimilar Drug Products Offered
11.5.5 Biotech Pharma Recent Development
12 Future Forecast
12.1 Biosimilar Drug Market Forecast by Regions
12.1.1 Global Biosimilar Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Biosimilar Drug Revenue Forecast by Regions 2019-2025
12.2 Biosimilar Drug Market Forecast by Product
12.2.1 Global Biosimilar Drug Sales Forecast by Product 2019-2025
12.2.2 Global Biosimilar Drug Revenue Forecast by Product 2019-2025
12.3 Biosimilar Drug Market Forecast by End User
12.4 North America Biosimilar Drug Forecast
12.5 Europe Biosimilar Drug Forecast
12.6 Asia Pacific Biosimilar Drug Forecast
12.7 Central & South America Biosimilar Drug Forecast
12.8 Middle East and Africa Biosimilar Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Biosimilar Drug Product Picture
Table Biosimilar Drug Market Segments
Table Key Manufacturers Biosimilar Drug Covered
Table Global Biosimilar Drug Market Size Growth Rate by Product 2019-2025 (K DDD) & (Million US$)
Figure Global Biosimilar Drug Sales Market Share by Product 2014-2025
Figure Injection Product Picture
Table Major Manufacturers of Injection
Figure Tablets Product Picture
Table Major Manufacturers of Tablets
Figure Other Types Product Picture
Table Major Manufacturers of Other Types
Table Global Biosimilar Drug Market Size Growth Rate by End User 2019-2025 (K DDD)
Figure Ankylosing Spondylitis
Figure Tumor
Figure Rheumatoid Arthrtis
Figure Cardiovascular
Figure Other Application
Figure Biosimilar Drug Report Years Considered
Figure Global Biosimilar Drug Market Size 2014-2025 (Million US$)
Figure Global Biosimilar Drug Sales 2014-2025 (K DDD)
Table Global Biosimilar Drug Market Size by Regions 2014-2019 (K DDD) & (Million US$)
Table Global Biosimilar Drug Sales by Regions 2014-2019 (K DDD)
Table Global Biosimilar Drug Sales Market Share by Regions 2014-2019
Figure Global Biosimilar Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Drug Sales Market Share by Regions
Table Global Biosimilar Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Biosimilar Drug Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Drug Revenue Market Share by Regions
Table Global Biosimilar Drug Sales by Manufacturers (2014-2019) (K DDD)
Table Global Biosimilar Drug Sales Share by Manufacturers (2014-2019)
Figure Global Biosimilar Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biosimilar Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Biosimilar Drug Revenue Share by Manufacturers (2014-2019)
Figure Biosimilar Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Biosimilar Drug Price (2014-2019) (USD/DDD)
Table Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilar Drug Product Type
Table Date of International Manufacturers Enter into Biosimilar Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table Global Biosimilar Drug Sales Share by Product (2014-2019)
Figure Global Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure Global Biosimilar Drug Sales Market Share by Product in 2018
Table Global Biosimilar Drug Revenue by Product (2014-2019) (Million US$)
Table Global Biosimilar Drug Revenue Share by Product (2014-2019)
Figure Global Biosimilar Drug Revenue Market Share by Product (2014-2019)
Figure Global Biosimilar Drug Revenue Market Share by Product in 2018
Table Biosimilar Drug Price by Product 2014-2019 (USD/DDD)
Table Global Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table Global Biosimilar Drug Sales Share by End User (2014-2019)
Figure Global Sales Biosimilar Drug Market Share by End User (2014-2019)
Figure Global Sales Biosimilar Drug Market Share by End User in 2018
Figure North America Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
Figure North America Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Drug Sales Market Share by Countries
Table North America Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Biosimilar Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Drug Revenue Market Share by Countries
Figure United States Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure United States Biosimilar Drug Revenue Growth Rate (2014-2019) (K DDD)
Figure Canada Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Canada Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Mexico Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Biosimilar Drug Market Share by Product
Table North America Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table North America Biosimilar Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Biosimilar Drug Market Share by End User
Figure Europe Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
Figure Europe Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Drug Sales Market Share by Countries
Table Europe Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Biosimilar Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Drug Revenue Market Share by Countries
Figure Germany Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Germany Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure France Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure UK Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Italy Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Russia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biosimilar Drug Market Share by Product
Table Europe Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biosimilar Drug Market Share by End User
Figure Asia Pacific Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
Figure Asia Pacific Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Drug Sales Market Share by Countries
Table Asia Pacific Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Drug Revenue Market Share by Countries
Figure China Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure China Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Japan Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Korea Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure India Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Australia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Indonesia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Malaysia Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Philippines Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Thailand Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Vietnam Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Singapore Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biosimilar Drug Market Share by Product
Table Asia Pacific Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biosimilar Drug Market Share by End User
Figure Central & South America Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
Figure Central & South America Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Drug Sales Market Share by Countries
Table Central & South America Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biosimilar Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Drug Revenue Market Share by Countries
Figure Brazil Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Brazil Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Argentina Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biosimilar Drug Market Share by Product
Table Central & South America Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biosimilar Drug Market Share by End User
Figure Middle East and Africa Biosimilar Drug Sales Growth Rate 2014-2019 (K DDD)
Figure Middle East and Africa Biosimilar Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biosimilar Drug Sales by Countries (2014-2019) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Drug Sales Market Share by Countries
Table Middle East and Africa Biosimilar Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Drug Revenue Market Share by Countries
Figure GCC Countries Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure GCC Countries Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Turkey Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure Egypt Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biosimilar Drug Sales Growth Rate (2014-2019) (K DDD)
Figure South Africa Biosimilar Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Drug Sales by Product (2014-2019) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Drug Market Share by Product
Table Middle East and Africa Biosimilar Drug Sales by End User (2014-2019) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Drug Market Share by End User
Table Amgen Company Details
Table Amgen Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table CP Guojian Pharma Company Details
Table CP Guojian Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
Table CP Guojian Pharma Recent Development
Table Biotech Pharma Company Details
Table Biotech Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2014-2019)
Table Biotech Pharma Recent Development
Table Global Biosimilar Drug Sales Forecast by Regions 2019-2025 (K DDD)
Table Global Biosimilar Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biosimilar Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Drug Sales Forecast by Product 2019-2025 (K DDD)
Table Global Biosimilar Drug Sales Market Share Forecast by Product 2019-2025
Table Global Biosimilar Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biosimilar Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Biosimilar Drug Sales Forecast by End User 2019-2025 (K DDD)
Table Global Biosimilar Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
Figure North America Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
Figure Europe Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
Figure Asia Pacific Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
Figure Central & South America Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biosimilar Drug Sales Growth Rate Forecast (2019-2025) (K DDD)
Figure Middle East and Africa Biosimilar Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biosimilar Drug Value Chain
Table Biosimilar Drug Customers List
Table Biosimilar Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
- PRICE
-
$3900$7800